<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) refractory to accepted medical therapy </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Six eyes of four patients with ocular BD refractory to steroids and <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> were treated with a course of intravenous gammaglobulin and followed up for their response to treatment </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> six eyes of <z:hpo ids='HP_0000001'>all</z:hpo> four patients showed good response to gammaglobulin therapy </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: Gamma globulin may have a role in treating refractory ocular BD </plain></SENT>
<SENT sid="4" pm="."><plain>A wide range of controlled studies with longer follow up is needed to substantiate this impression </plain></SENT>
</text></document>